subscribeSubscribe
FDA Confirms Paragraph IV Patent Litigation for Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets

FDA Confirms Paragraph IV Patent Litigation for Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
FDA
20 Nov 2023
Share Share
FDA Confirms Para IV Patent Litigation for Bictegravir Sodium, Emtricitabine, Tenofovir Alafenamide Fumarate Tablet

FDA Confirms Para IV Patent Litigation for Bictegravir Sodium, Emtricitabine, Tenofovir Alafenamide Fumarate Tablet
FDA
06 Apr 2022
Share Share
FDA Unveils 34 New and Revised Product-Specific Draft Guidances

FDA Unveils 34 New and Revised Product-Specific Draft Guidances
Ana Mulero RAPS
17 May 2019
Share Share
Singapore HSA Approves Biktarvy for Treatment of HIV-1 Infection

Singapore HSA Approves Biktarvy for Treatment of HIV-1 Infection
PR NEWSWIRE
13 Feb 2019
Share Share
GSK looks to oncology for growth as Advair generic hits

GSK looks to oncology for growth as Advair generic hits
Angus Liu FIERCE PHARMA
06 Feb 2019
Share Share
Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV

Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
Alex Keown BIOSPACE
22 Jan 2019
Share Share
European Commission Grants Marketing Authorization for Gilead’s Biktarvy®

European Commission Grants Marketing Authorization for Gilead’s Biktarvy®
PRESS RELEASE
23 Jun 2018
Share Share
GSK vs Gilead: Heavyweight HIV fight will come down to big showdown in Amsterdam

GSK vs Gilead: Heavyweight HIV fight will come down to big showdown in Amsterdam
John Carroll ENDPTS
21 Jun 2018
Share Share
Three medicines step closer to EU approval

Three medicines step closer to EU approval
Selina McKee PHARMA TIMES
01 May 2018
Share Share
Gilead strikes back at GSK with +ve HIV head-to-head trial data for blockbuster

Gilead strikes back at GSK with +ve HIV head-to-head trial data for blockbuster
A. Weintraub FIERCE PHARMA
07 Mar 2018
Share Share